Marinus Pharmaceuticals
MRNS
$1.51
Share price
4.14%
Change (1 day)
-83.22%
Change (1 year)
Categories
EPS for Marinus Pharmaceuticals (MRNS)
EPS in 2023 (TTM): -$0.11
According to Marinus Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.11. In 2022 the company made an earnings per share (EPS) of -$0.41 an increase over its 2021 EPS that were of -$2.69.
EPS history for Marinus Pharmaceuticals from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.11 | -73.17% |
| 2022 | -$0.41 | -84.76% |
| 2021 | -$2.69 | -9.12% |
| 2020 | -$2.96 | -25.81% |
| 2019 | -$3.99 | 10.83% |
| 2018 | -$3.60 | 9.76% |
| 2017 | -$3.28 | -44.22% |
| 2016 | -$5.88 | -12.5% |
| 2015 | -$6.72 | 34.49% |
| 2014 | -$5.00 | 11.01% |
| 2013 | -$4.50 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | $0.79 | -818.18% | 🇺🇸 USA |
 Endo International
ENDPQ | -$4.02 | 3,554.55% | 🇮🇪 Ireland |
 AcelRx Pharmaceuticals
ACRX | -$3.09 | 2,709.09% | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | $0.92 | -936.36% | 🇺🇸 USA |